ADAM33 and cystic fibrosis: These findings support the potential role for ADAM33 rs2280091 as a modifier gene contributing to phenotypic variability in CF while emphasizing the need to interpret allele frequency shifts within the context of Hardy–Weinberg equilibrium deviation.